DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on September 12, 2007; DOI: 10.1124/dmd.107.014845


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.014845v1
36/1/16    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, H.
Right arrow Articles by Klaassen, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, H.
Right arrow Articles by Klaassen, C. D.


Received for publication January 23, 2007.
Revised September 10, 2007.
Accepted for publication September 11, 2007.

GENDER DIFFERENCES IN mRNA EXPRESSION OF ABC EFFLUX AND BILE ACID TRANSPORTERS IN KIDNEY, LIVER, AND INTESTINE OF 5/6 NEPHRECTOMIZED RATS

Hong Lu 1 Curtis D. Klaassen 1*

1 University of Kansas Medical Center

* Address correspondence to: E-mail: cklaasse{at}kumc.edu

Abstract

ABC transporters including multi-drug resistance proteins (Mdr), multi-drug resistance-associated proteins (Mrp), and breast cancer resistance protein (Bcrp/Abcg2) play major roles in tissue defense. Abcg5/g8 is essential in cholesterol efflux. The present study was aimed at elucidating alteration in expression of these transporters and bile-acid transporters during chronic kidney disease (CKD) and underlying molecular mechanisms. Seven weeks after 5/6 nephrectomy (Nx), mRNA expression of 16 aforementioned transporters in kidney, liver, jejunum, and large intestine of male and female Nx rats was quantified with the branched DNA signal amplification assay. In Nx-males, intestinal expression of all transporters remained unchanged; hepatic expression of most transporters was not altered, except increases in Mdr1a, Mrp3, and Abcg8. In male remnant kidneys, kidney-predominant transporter Abcg2 decreased and correlated with CKD severity, whereas Mdr1b, Mrp3, and Ileal bile-acid transporter increased and correlated with CKD severity. Such changes were largely absent in Nx-females. Renal alterations of these transporters correlated with increases of cytokines and/or decreases of nuclear receptors such as estrogen receptor alpha and glucocorticoid receptor. Renal protein expression of Mrp2 increased, whereas that of Mrp4 remained unchanged in both genders of Nx-rats. Treatment of rat proximal tubule NRK-52E cells with interleukin-1{beta} and interleukin-6 increased Mrp3 mRNA expression. In conclusion, during CKD, renal expression of many ABC transporters was altered at the transcriptional level, whereas hepatic mRNA expression of most ABC transporters remained unchanged. Down-regulation of steroid hormone receptors and increase of inflammatory cytokines may contribute to alteration of transporter gene expression in kidney during chronic kidney disease.


Key words: ABC transporters, bile acid transport, cholesterol, chronic renal failure, cytokines, drug efflux, drug transport, MRP, multi-drug resistance, transporters





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.